Solving Challenges in Contraceptive Discovery and Innovation

September 30 Session

Novel Contraceptives Targeting Sperm Development and Function

4:00 - Keynote Speaker: Martin Matzuk, Baylor College of Medicine, USA
DNA-Encoded Chemistry Technology and Functional Genomics for Contraception Research

4:45 - Laura Giojalas, National University of Cordoba, Argentina 
Sperm Chemotaxis And Its Potential Application For New Contraceptive Development

5:00- Mariano Buffone, Institute of Biology and Experimental Medicine, Argentina 
Sperm Acrosome Reaction and Capacitation and The Potential Application For New Contraceptive Development

5:15 - Aaron Crapster, Vibliome Therapeutics Stanford University, USA
HIPK4-Selective Inhibitors for Male Contraception

5:30 - Alan Andrew Silva, São Paulo State University, Brazil 
The Roles of Epididymal Protease Inhibitor (EPPIN) N-Terminal and C-Terminal Regions on The Regulation of Mouse Sperm Motility

5:40 - Noemia Mariani, São Paulo State University, Brazil 
Recombinant Seminal Vesicle-Secreted Protein SVS2 Inhibits the Motility of Mouse Spermatozoa in vitro

5:50 - Nongnuj Tanphaichitr, University of Ottawa, Canada 
Potential Use of LL-37/17BIPHE2 as Vaginal Spermicides/Microbicides

October 7 Session

Male Contraceptive Development Targeting Spermatogenesis

4:00 - Keynote Speaker: Patricia Cuasnicú, Institute of Biology and Experimental Medicine, Argentina
CRISP Proteins as Novel Targets for Male Contraceptive Development

4:45 - Gustavo Blanco, Kansas University Medical Center, USA
Targeting Na,K-ATPase Alpha 4 for Male Contraception

5:00 - John Amory, University of Washington, USA 
Inhibition of Retinoic Acid Biosynthesis as A Target for Male Contraception

5:15 - Wei Yan, David Geffen School of Medicine at UCLA, USA
SD-1 Is A Reversible, Non-Hormonal Male Contraceptive Agent

5:30 - Asifu Basiru, University of Ilorin, Nigeria
Waltheria Indica Linn. Root Exhibits Male Contraceptive Effect Through Inhibition of Androgensis In Male Wistar Rats

5:40 - Haiqi Chen, Broad Institute of MIT and Harvard, USA
Testicular Spatial Transcriptome Atlas Reveals Functional Dynamics in Gene Programs During Mammalian Spermatogenesis

5:50 - Maximilian Lyon, Washington University School of Medicine
The Sperm-Specific Potassium Channel SLO3 is a Target for Contraceptive Development

October 14 Session

Non-Hormonal Female Contraceptive Strategies  

4:00 Keynote Speaker: Diane Duffy, Eastern Virginia Medical School, USA
Ovulatory Angiogenesis as a Target for Novel Contraceptive Development

4:45 - Shuo Xiao, Rutgers University, USA
3D In Vitro Follicle Culture as An Effective Model for Contraceptive Discovery

5:00 - Marina Peluffo, Centro de Investigaciones Endocrinológicas (CEDIE), Argentina
Chemokines and Their Potential Application for New Female Contraceptive Development

5:15 - Sergio Romero, by Universidad Peruana Cayetano Heredia, Peru            
Oocyte Maturation Mechanism.  Potential Targets for Contraception

5:30 - Doan Thao Dinh, University of Adelaide, Australia
Unique Molecular Mechanism of Progesterone Receptor in Granulosa Cells during Ovulation

5:40 - Emily Harris, Washington State University, USA     
Progesterone Signaling in the Oviduct Epithelial Cells is Required for Normal Embryo Transport and Development

5:50 - Jiyang Zhang, Northwestern University, USA
Mouse Ovarian Follicles from Encapsulated in Vitro Follicle Growth (eIVFG) Preserve Ovulation Molecular Signatures in Vivo